Skip to main content

Table 4 Univariable and multivariable analyses of RFS before and after PSM

From: Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched study

Variables

Before PSM (n = 170)

After PSM (n = 105)

Univariable analysis

Multivariable analysis

Univariable analysis

Multivariable analysis

HR

95% Cl

p-value

HR

95% Cl

p-value

HR

95% Cl

p-value

HR

95% Cl

p-value

Age

0.994

0.974–1.015

0.577

   

0.999

0.973–1.026

0.970

   

Gender, female vs. male

0.680

0.445–1.039

0.075

0.533

0.296–0.958

0.036

0.649

0.386–1.093

0.104

   

BMI

0.945

0.881–1.014

0.115

   

0.953

0.875–1.037

0.261

   

ASA score, high vs low

0.919

0.384–2.195

0.849

   

0.861

0.293–2.528

0.785

   

Cirrhosis, yes vs. no

1.057

0.586–1.906

0.854

   

1.083

0.514–2.286

0.833

   

Hepatitis B, yes vs. no

1.261

0.764–2.082

0.364

   

1.261

0.678–2.346

0.463

   

TBIL, high vs low

1.071

0.592–1.939

0.820

   

1.285

0.626–2.637

0.494

   

ALB, low vs high

0.714

0.464–1.098

0.125

   

0.719

0.427–1.211

0.215

   

PT, high vs low

1.124

0.595–2.121

0.719

   

1.023

0.437–2.395

0.958

   

PLT, low vs high

1.688

1.049–2.718

0.031

2.291

1.259–4.168

0.007

1.453

0.807–2.616

0.213

   

AFP, high vs low

1.558

0.676–3.590

0.298

   

1.569

0.620–3.967

0.341

   

CEA, high vs low

1.114

0.685–1.810

0.664

   

0.934

0.504–1.730

0.828

   

CA19-9, high vs low

1.538

0.956–2.475

0.076

1.367

0.731–2.559

0.328

1.715

0.967–3.041

0.065

1.171

0.584–2.346

0.657

CA12-5, high vs low

1.785

1.103–2.887

0.018

1.057

0.565–1.978

0.863

1.766

0.992–3.143

0.053

0.710

0.312–1.615

0.414

Child–Pugh, high vs low

0.753

0.347–1.633

0.473

   

0.349

0.048–2.542

0.299

   

Surgical operation, open vs laparoscopic

1.181

0.726–1.919

0.503

   

1.320

0.761–2.288

0.323

   

Anatomical liver resection, yes vs. no

0.868

0.545–1.382

0.550

   

0.942

0.535–1.660

0.837

   

Extent of resection, major vs minor

1.102

0.938–1.295

0.238

   

1.147

0.941

1.398

   

Lymphadenectomy ≥ 6, yes vs. no

1.388

0.907–2.124

0.131

   

1.396

0.825–2.363

0.214

   

Operation time

1.002

1.000–1.003

0.069

0.999

0.997–1.002

0.603

1.001

0.999–1.004

0.251

   

Blood transfusion, yes vs. no

1.518

0.991–2.325

0.055

0.875

0.466–1.641

0.676

1.676

1.003–2.801

0.049

1.244

0.601–2.575

0.556

Blood loss

1.000

1.000–1.000

0.311

   

1.000

1.000–1.000

0.319

   

Tumor sizes

1.133

1.052–1.221

0.001

1.139

1.027–1.264

0.014

1.116

1.020–1.220

0.016

1.074

0.933–1.235

0.322

No. of tumors, multiple vs solitary

2.470

1.492–4.090

< 0.001

1.763

0.948–3.279

0.074

3.435

1.687–6.996

0.001

3.501

1.540–7.957

0.003

Clavien-Dindo classification, major vs minor/none

1.039

0.575–1.877

0.900

   

0.757

0.104–5.509

0.784

   

Postoperative hospital stay

1.016

1.003–1.030

0.016

1.010

0.992–1.029

0.271

1.019

1.001–1.038

0.036

1.019

0.998–1.040

0.070

Tumor differentiation, low vs. high

1.232

0.905–1.678

0.185

   

1.151

0.788–1.681

0.467

   

Lymph node metastasis, yes vs. no

2.573

1.634–4.051

< 0.001

2.140

1.220–3.752

0.008

2.781

1.597–4.846

< 0.001

2.427

1.284–4.589

0.006

Nerve invasion, yes vs. no

2.217

1.371–3.585

0.001

2.451

1.286–4.674

0.006

2.412

1.285–4.525

0.006

2.227

0.891–5.568

0.087

R0 resection, yes vs. no

1.215

0.491–3.006

0.673

   

0.559

0.219–1.426

0.224

  Â